The majority of tumor cells from six of the patients analyzed were assigned to the group with abnormal activation of WNT/β-catenin and MYC signaling pathways, frequent somatic copy number alterations (SCNAs), and no hypermutation. The gene discussed is MYC; the disease is neoplasm.